From: The cGAS-STING pathway in COPD: targeting its role and therapeutic potential
cGAS and STING Antagonists | Name | Molecular mechanism | References |
---|---|---|---|
cGAS inhibitors | Hydroxychloroquine | Disrupting DNA binding | [69] |
 | Quinacrine |  | [69] |
 | X6 |  | [70] |
 | A151 |  | [71] |
 | Suramin |  | [72] |
 | RU.521 | Occupying cGAS Catalytic site | [73] |
 | PF-06928125 |  | [74] |
STING inhibitors | Tetrahydroisoquinolinone acetate (Compound 18) | Targeting the CDN-binding site | [75] |
 | Astin C |  | [76] |
 | Nitrofuran derivatives(C-170, C-171, etc.) | Targeting STING palmitoylation sites | [77] |
Unknown inhibitors | CU-32 and CU-76 | unknown mechanisms | [78] |
 | VS-X4 |  | [79] |